Thursday October 4th
Thursday October 4th, Palais de l’Europe, Menton
Presentations are available for viewing in PDF format but should not be used without authors’ permission
07.00 – 08.30
Poster mounting and attendee registration
08.00 – 08.30: Opening
B. Coiffier, M. Federico, M. Meignan , A. Gallamini , C. Haioun, A. Polliack
08.30 – 11.30: International Workshop on PET in lymphoma staging and restaging
Chairmen: B. Cheson, A. Lister, R. Fisher
S. Barrington and Nuclear Medicine task force
(including 15 min coffee break)
- New recommendations – summary of the workshop (S. Barrington)
- When to use PET-CT (L. Kostakoglu)
- Imaging of bone marrow (M. Hutchings)
- Assessment of bulk (L. Schwartz)
- Mid treatment assessment (G. Mikhaeel)
- Significance of residual masses (G. Mikhaeel)
- Quantitation 1 – standardisation (S. Müller)
- Quantitation 2 – use of the δSUV (M. Meignan)
- Conclusion : proposed new response criteria (G. Mikhaeel)
11.30 – 12.00: Economic perspectives of PET in lymphoma
Chairman: E. Zucca
J.J. Cerci
Session sponsored by a restricted grant from Amgen
12.00 – 14.00: Poster viewing and Lunch
14.00 – 15.30: Afternoon controversies
Is PET useful in non-Hodgkin lymphoma other than DLBCL
Moderators: S. Luminari, F. Bodéré, M. Meignan, B. Coiffier
14.00 – 14.30: Follicular lymphoma
The role of PET/CT in the management of Follicular lymphoma: predictive and prognostic roles
J. Trotman, M. Federico
14.30 – 15.30: Other lymphoma subtypes
Potential applications of PET/CT in MALT and PMBCL: L. Ceriani, G. Paone, E. Zucca
Potential applications of PET/CT in mantle cell lymphoma: S. le Gouill, C. Bodet-Millin
Potential applications of PET/CT in T-cell lymphoma: C. Moskowitz, H. Schöder
15.30 – 15.45: Coffee break
15.45 – 16.15
SNMMI and scientific and educational cooperation: F. Fahey
EANM policy and Menton meeting: A. Chiti
16.15 – 17.45; Interim PET in early-stage Hodgkin lymphoma
Moderators: O. Casasnovas, S. Bardet
Round table: intergroup trials
J. Radford, M. André, A. Engert, M. Federico, M. Hutchings, M. Meignan, A. Versari
PET in H10 trial: an interim analysis
- H10 trial (C. Fortpied)
- H10 trial (M. André)
20.00: Gala dinner